 |
|
| |
|
| |
|
|
|
Which IOLs are most popular in your practice
Monofocals |
58% |
Multifocals |
17% |
Trifocals |
6% |
Phakic IOLs |
6% |
Accommodating IOLs |
3% |
Toric IOLs |
7% |
Other |
3% |
|
|
|
|
|
|
You can now follow us on Twitter:
www.twitter.com/oteurope
Contact Us
Click here to contact Felicity Thomas, editor.
|
|
|
March 4, 2015 |
|
DME therapy
Comparing anti-VEGFs for DME
In a 1-year comparison of intravitreous aflibercept, bevacizumab and ranibizumab therapy for centre-involved DME, aflibercept was more effective at improving vision among patients who started treatment at lower levels of visual acuity. More... |
|
FLACS prostaglandin release
Capsulotomy triggers prostaglandin release in FLACS
Anterior capsulotomy triggers an increase of prostaglandins in the aqueous humour immediately after FLACS, according to researchers from Ruhr University Eye Hospital, Bochum, Germany. More... |
|
AREDS predicts progression
Lens opacity AREDS score predicts progression
Researchers using the AREDS lens grading scale have found that long-term clinically relevant outcomes can be predicted by 2-year changes in severity of lens opacities. More... |
|
| Product Profile |
The New Humphrey Field Analyzer 3 from ZEISS
Setting a New Standard for Efficient Visual Field Testing
The New HFA3 offers gold-standard perimetry performance with technological advances – such as automated trial lens correction with liquid lens technology – that are designed to save time and reduce errors.
 Read more
|  |
|
|
| Supplements |
 Challenging our Treatment Approach in AMD
The increasing importance of regimen and practicality.  Read more |
|
|
|
A Closer Look at Safety
Reviewing and updating the important issues surrounding anti-VEGF therapy.
 Read more
*Please note: Those residing in Germany will be unable to access this supplement
|
|
|
Event Profile |
 The 6th World Congress on Controversies in Ophthalmology (COPHy)
Dates: March 26-29, 2015
Venue: Sorrento Palace, Via S Antonio n. 13, Sorrento 80067, Italy
The great success of the previous five COPHy Congresses, held in Prague, Barcelona, Istanbul, Budapest, Lisbon, and the enthusiastic feedback from the latest Congress illustrated the need for this dynamic Congress. We are excited to disclose that COPHy Sorrento will again be devoted to evidence-based debates and discussions amongst chairpersons, speakers and the audience, all of whom will examine and analyze the most relevant issues raised during the course of 2014 within the field of ophthalmology.
This educational Congress will continue to focus on Anterior Segment, Glaucoma, and Retina sections, and will discuss controversies in other areas of ophthalmology, such as neuro-ophthalmology, as well.
The Scientific Program will include overviews, state of the art lectures and controversial debates. Outstanding world leaders as faculty will present both pro and con positions while further challenging and exploring the optimal treatment for patients, with emphasis on the appropriate use of new and emerging drugs. This format includes a substantial allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
Website:
 http://www.comtecmed.com/cophy/2015/
Registration:
 http://www.comtecmed.com/cophy/2015/Registration.aspx
Contact: Esther Tobias:
 [email protected]
|
|
|
|
|
|
